Aprocitentan
CAS 1103522-45-7Small Molecule
Overview
Aprocitentan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2165326).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Aprocitentan expires 26 Jul 2038 and exclusivity 22 Mar 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine
- Canonical SMILES
- C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br
- InChIKey
- DKULOVKANLVDEA-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Aprocitentan? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.